SCHEMBL607401

SCHEMBL607401

CC(C)=CC1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.35
GRIK1 P39086 2/20 0.34
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA4 P22748 1/20 0.33
GRIK2 Q13002 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11102174 0.97
SCHEMBL2693981 0.84
SCHEMBL9682196 0.80 GRIK1 (0.37) GRIK1GRIK2
SCHEMBL7636887 0.78 GRIK1 (0.32) GRIK1
SCHEMBL7636890 0.78 GRIK1 (0.32) GRIK1
SCHEMBL24528765 0.77 TSHR (0.35) TSHR
SCHEMBL12166727 0.77 TSHR (0.35) TSHR
SCHEMBL23199650 0.74 GRIK1 (0.34) GRIK1GRIK2
SCHEMBL23199651 0.74 GRIK1 (0.34) GRIK1GRIK2
SCHEMBL15173030 0.74 GRIK1 (0.34) GRIK1GRIK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2875053-B1 ADJUSTING POLYMER COMPOSITION NOVA CHEM INT SA (CH) 2022-09-14 EP disclosed
US-20210227864-A1 FRAGRANCE AND FLAVOR MATERIALS TAKASAGO INTERNATIONAL CORPORATION (JP) 2021-07-29 US disclosed
US-11066493-B2 Catalyst injection system for an olefin polymerization reactor NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2021-07-20 US disclosed
US-10987647-B2 Multistage catalyst injection system for an olefin polymerization reactor NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2021-04-27 US disclosed
US-20200055969-A1 CATALYST INJECTION SYSTEM FOR AN OLEFIN POLYMERIZATION REACTOR NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2020-02-20 US disclosed
EP-2875053-A1 ADJUSTING POLYMER COMPOSITION Nova Chemicals (International) S.A. (CH) 2015-05-27 EP disclosed
US-20140363599-A1 Adjusting Polymer Composition NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2014-12-11 US disclosed
US-8846835-B2 Adjusting polymer composition NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2014-09-30 US disclosed
WO-2014015412-A1 ADJUSTING POLYMER COMPOSITION NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2014-01-30 WO disclosed
US-20140024789-A1 ADJUSTING POLYMER COMPOSITION NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2014-01-23 US disclosed
WO-2012019276-A1 COMBINING ACTIVITY MODIFIERS AND MULTI COMPONENT CATALYSTS FOR CONTROL OF POLYMER ARCHITECTURE NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2012-02-16 WO disclosed
US-20120041147-A1 Method of controlling polymer architecture NOVA CHEMICALS (INTERNATIONAL) S.A. 2012-02-16 US disclosed
US-7745658-B2 Process for preparing tertiary alkyl esters of (meth)acrylic acid having at least 4 carbon atoms in the alkyl radical BASF SE (DE) 2010-06-29 US disclosed
CN-101629067-A Natural solvent used for producing spray LIJIE HUANG 2010-01-20 CN disclosed
US-20090023947-A1 PROCESS FOR PREPARING TERTIARY ALKYL ESTERS OF (METH) ACRYLIC ACID HAVING AT LEAST 4 CARBON ATOMS IN THE ALKYL RADICAL BASF SE (DE) 2009-01-22 US disclosed
WO-1990000399-A1 RETROVIRAL PROTEASE BINDING PEPTIDES SMITHKLINE BECKMAN CORPORATION (US) 1990-01-25 WO disclosed
EP-0352000-A2 Retroviral protease binding peptides SMITHKLINE BEECHAM CORPORATION (US) 1990-01-24 EP disclosed
US-4827070-A DEHYDROISOMERIZATION WITH CATALYST IN PRESENCE OF OXYGEN FOR BY-PRODUCT INHIBITION BP CHEMICALS LIMITED (GB) 1989-05-02 US disclosed
US-4467116-A Process for the hydroformylation of olefins SHELL OIL COMPANY (US) 1984-08-21 US disclosed
EP-0054986-A1 A process for the hydroformylation of olefins SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1982-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023947-A1 PROCESS FOR PREPARING TERTIARY ALKYL ESTERS OF (METH) ACRYLIC ACID HAVING AT LEAST 4 CARBON ATOMS IN THE ALKYL RADICAL ACSL3, ACSL1, ACSL4 TSHR 1270/4885GRIK1 1618/4885CA1 3496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.